APO Research
Talk to an analyst

APO RESEARCH · REPORT

Thrombin (Human)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Thrombin (Human) Market Outlook and Growth Opportunities 2026

26 December 2025198 pages

Choose your research edition.

Industry ResearchThrombin (Human) Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Thrombin (Human) Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Thrombin (Human) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Thrombin (Human) Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Thrombin (Human) Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Thrombin (Human) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Thrombin (Human) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Thrombin (Human) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Thrombin (Human) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Thrombin (Human) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Thrombin (Human) market include Shanghai RAAS, Hualan Biological, Bayer, Baxter, Vitrolife AB, Sigma-Aldrich Corporation, PromoCell GmbH, Octapharma and Life Technologies Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Thrombin (Human) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Thrombin (Human) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Thrombin (Human) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Thrombin (Human) market size, projected growth trends, production technologies, key applications, and end-use industries.

Thrombin (Human) Segment by Company

Shanghai RAAS

Hualan Biological

Bayer

Baxter

Vitrolife AB

Sigma-Aldrich Corporation

PromoCell GmbH

Octapharma

Life Technologies Corporation

Kedrion

Grifols

CSL

BD Biosciences

AMRESCO Inc

Thrombin (Human) Segment by Type

500IU/Vial

1000IU/Vial

2500IU/Vial

Thrombin (Human) Segment by Application

Biotechnology

Microbiology

Medicine

Others

Thrombin (Human) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Thrombin (Human) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Thrombin (Human) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Thrombin (Human) significant trends, drivers, influence factors in global and regions.

6. To analyze Thrombin (Human) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Thrombin (Human) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Thrombin (Human) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Thrombin (Human).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Thrombin (Human) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Thrombin (Human) industry.

Chapter 3: Detailed analysis of Thrombin (Human) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Thrombin (Human) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Thrombin (Human) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Thrombin (Human) Industry Trends Table 2. Thrombin (Human) Industry Drivers Table 3. Thrombin (Human) Industry Opportunities and Challenges Table 4. Thrombin (Human) Industry Restraints Table 5. Global Thrombin (Human) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Thrombin (Human) Revenue Share by Company (2021-2026) Table 7. Global Thrombin (Human) Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Thrombin (Human) Sales Volume Share by Company (2021-2026) Table 9. Global Thrombin (Human) Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Thrombin (Human) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Thrombin (Human) Key Company Manufacturing Base & Headquarters Table 12. Global Thrombin (Human) Company, Product Type & Application Table 13. Global Thrombin (Human) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Thrombin (Human) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 500IU/Vial Table 18. Significant Companies of 1000IU/Vial Table 19. Significant Companies of 2500IU/Vial Table 20. Global Thrombin (Human) Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Thrombin (Human) Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Thrombin (Human) Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Thrombin (Human) Sales Volume Share by Type (2021-2026) Table 24. Global Thrombin (Human) Sales Volume Share by Type (2027-2032) Table 25. Global Thrombin (Human) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Thrombin (Human) Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Thrombin (Human) Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Thrombin (Human) Sales Value Share by Type (2021-2026) Table 29. Global Thrombin (Human) Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Biotechnology Table 31. Significant Companies of Microbiology Table 32. Significant Companies of Medicine Table 33. Significant Companies of Others Table 34. Global Thrombin (Human) Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Thrombin (Human) Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Thrombin (Human) Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Thrombin (Human) Sales Volume Share by Application (2021-2026) Table 38. Global Thrombin (Human) Sales Volume Share by Application (2027-2032) Table 39. Global Thrombin (Human) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Thrombin (Human) Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Thrombin (Human) Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Thrombin (Human) Sales Value Share by Application (2021-2026) Table 43. Global Thrombin (Human) Sales Value Share by Application (2027-2032) Table 44. Global Thrombin (Human) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Thrombin (Human) Sales by Region (2021-2026) & (K Units) Table 46. Global Thrombin (Human) Sales Market Share by Region (2021-2026) Table 47. Global Thrombin (Human) Sales by Region (2027-2032) & (K Units) Table 48. Global Thrombin (Human) Sales Market Share by Region (2027-2032) Table 49. Global Thrombin (Human) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Thrombin (Human) Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Thrombin (Human) Sales Value Share by Region (2021-2026) Table 52. Global Thrombin (Human) Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Thrombin (Human) Sales Value Share by Region (2027-2032) Table 54. Global Thrombin (Human) Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Thrombin (Human) Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Thrombin (Human) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Thrombin (Human) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Thrombin (Human) Sales by Country (2021-2026) & (K Units) Table 59. Global Thrombin (Human) Sales Market Share by Country (2021-2026) Table 60. Global Thrombin (Human) Sales by Country (2027-2032) & (K Units) Table 61. Global Thrombin (Human) Sales Market Share by Country (2027-2032) Table 62. Global Thrombin (Human) Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Thrombin (Human) Sales Value Market Share by Country (2021-2026) Table 64. Global Thrombin (Human) Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Thrombin (Human) Sales Value Market Share by Country (2027-2032) Table 66. Shanghai RAAS Company Information Table 67. Shanghai RAAS Business Overview Table 68. Shanghai RAAS Thrombin (Human) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Shanghai RAAS Thrombin (Human) Product Portfolio Table 70. Shanghai RAAS Recent Development Table 71. Hualan Biological Company Information Table 72. Hualan Biological Business Overview Table 73. Hualan Biological Thrombin (Human) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Hualan Biological Thrombin (Human) Product Portfolio Table 75. Hualan Biological Recent Development Table 76. Bayer Company Information Table 77. Bayer Business Overview Table 78. Bayer Thrombin (Human) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Bayer Thrombin (Human) Product Portfolio Table 80. Bayer Recent Development Table 81. Baxter Company Information Table 82. Baxter Business Overview Table 83. Baxter Thrombin (Human) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Baxter Thrombin (Human) Product Portfolio Table 85. Baxter Recent Development Table 86. Vitrolife AB Company Information Table 87. Vitrolife AB Business Overview Table 88. Vitrolife AB Thrombin (Human) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Vitrolife AB Thrombin (Human) Product Portfolio Table 90. Vitrolife AB Recent Development Table 91. Sigma-Aldrich Corporation Company Information Table 92. Sigma-Aldrich Corporation Business Overview Table 93. Sigma-Aldrich Corporation Thrombin (Human) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Sigma-Aldrich Corporation Thrombin (Human) Product Portfolio Table 95. Sigma-Aldrich Corporation Recent Development Table 96. PromoCell GmbH Company Information Table 97. PromoCell GmbH Business Overview Table 98. PromoCell GmbH Thrombin (Human) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. PromoCell GmbH Thrombin (Human) Product Portfolio Table 100. PromoCell GmbH Recent Development Table 101. Octapharma Company Information Table 102. Octapharma Business Overview Table 103. Octapharma Thrombin (Human) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Octapharma Thrombin (Human) Product Portfolio Table 105. Octapharma Recent Development Table 106. Life Technologies Corporation Company Information Table 107. Life Technologies Corporation Business Overview Table 108. Life Technologies Corporation Thrombin (Human) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Life Technologies Corporation Thrombin (Human) Product Portfolio Table 110. Life Technologies Corporation Recent Development Table 111. Kedrion Company Information Table 112. Kedrion Business Overview Table 113. Kedrion Thrombin (Human) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Kedrion Thrombin (Human) Product Portfolio Table 115. Kedrion Recent Development Table 116. Grifols Company Information Table 117. Grifols Business Overview Table 118. Grifols Thrombin (Human) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Grifols Thrombin (Human) Product Portfolio Table 120. Grifols Recent Development Table 121. CSL Company Information Table 122. CSL Business Overview Table 123. CSL Thrombin (Human) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. CSL Thrombin (Human) Product Portfolio Table 125. CSL Recent Development Table 126. BD Biosciences Company Information Table 127. BD Biosciences Business Overview Table 128. BD Biosciences Thrombin (Human) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. BD Biosciences Thrombin (Human) Product Portfolio Table 130. BD Biosciences Recent Development Table 131. AMRESCO Inc Company Information Table 132. AMRESCO Inc Business Overview Table 133. AMRESCO Inc Thrombin (Human) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. AMRESCO Inc Thrombin (Human) Product Portfolio Table 135. AMRESCO Inc Recent Development Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. Thrombin (Human) Distributors List Table 139. Thrombin (Human) Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Thrombin (Human) Product Image Figure 2. Global Thrombin (Human) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Thrombin (Human) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Thrombin (Human) Sales (2021-2032) & (K Units) Figure 5. Global Thrombin (Human) Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Thrombin (Human) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 500IU/Vial Image Figure 10. 1000IU/Vial Image Figure 11. 2500IU/Vial Image Figure 12. Global Thrombin (Human) Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Thrombin (Human) Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Thrombin (Human) Sales Volume Share by Type (2021-2032) Figure 15. Global Thrombin (Human) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Thrombin (Human) Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Thrombin (Human) Sales Value Share by Type (2021-2032) Figure 18. Biotechnology Image Figure 19. Microbiology Image Figure 20. Medicine Image Figure 21. Others Image Figure 22. Global Thrombin (Human) Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Thrombin (Human) Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Thrombin (Human) Sales Volume Share by Application (2021-2032) Figure 25. Global Thrombin (Human) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Thrombin (Human) Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Thrombin (Human) Sales Value Share by Application (2021-2032) Figure 28. Global Thrombin (Human) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Thrombin (Human) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Thrombin (Human) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Thrombin (Human) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Thrombin (Human) Sales Value (2021-2032) & (US$ Million) Figure 33. North America Thrombin (Human) Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Thrombin (Human) Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Thrombin (Human) Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Thrombin (Human) Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Thrombin (Human) Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Thrombin (Human) Sales Value (2021-2032) & (US$ Million) Figure 39. South America Thrombin (Human) Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Thrombin (Human) Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Thrombin (Human) Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Thrombin (Human) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Thrombin (Human) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Thrombin (Human) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Thrombin (Human) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Thrombin (Human) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Thrombin (Human) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Thrombin (Human) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Thrombin (Human) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Thrombin (Human) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Thrombin (Human) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Thrombin (Human) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Thrombin (Human) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Thrombin (Human) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Thrombin (Human) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Thrombin (Human) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Thrombin (Human) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Thrombin (Human) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Thrombin (Human) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Thrombin (Human) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Thrombin (Human) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Thrombin (Human) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Thrombin (Human) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Thrombin (Human) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Thrombin (Human) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Thrombin (Human) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Thrombin (Human) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Thrombin (Human) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Thrombin (Human) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Thrombin (Human) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Thrombin (Human) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Thrombin (Human) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Thrombin (Human) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Thrombin (Human) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Thrombin (Human) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Thrombin (Human) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Thrombin (Human) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Thrombin (Human) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Thrombin (Human) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Thrombin (Human) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Thrombin (Human) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Thrombin (Human) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Thrombin (Human) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Thrombin (Human) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Thrombin (Human) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Thrombin (Human) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Thrombin (Human) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Thrombin (Human) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Thrombin (Human) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Thrombin (Human) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Thrombin (Human) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Thrombin (Human) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Thrombin (Human) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Thrombin (Human) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Thrombin (Human) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Thrombin (Human) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Thrombin (Human) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Thrombin (Human) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Thrombin (Human) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Thrombin (Human) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Thrombin (Human) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Thrombin (Human) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Thrombin (Human) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Thrombin (Human) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Thrombin (Human) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Thrombin (Human) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Thrombin (Human) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Thrombin (Human) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Thrombin (Human) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Thrombin (Human) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Thrombin (Human) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Thrombin (Human) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Thrombin (Human) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Thrombin (Human) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Thrombin (Human) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Thrombin (Human) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Thrombin (Human) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Thrombin (Human) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Thrombin (Human) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Thrombin (Human) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Thrombin (Human) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Thrombin (Human) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Thrombin (Human) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Thrombin (Human) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Thrombin (Human) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Thrombin (Human) Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Thrombin (Human) Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • 500IU/Vial
  • 1000IU/Vial
  • 2500IU/Vial
Applications
  • Biotechnology
  • Microbiology
  • Medicine
  • Others
Companies covered
  • Shanghai RAAS
  • Hualan Biological
  • Bayer
  • Baxter
  • Vitrolife AB
  • Sigma-Aldrich Corporation
  • PromoCell GmbH
  • Octapharma
  • Life Technologies Corporation
  • Kedrion
  • Grifols
  • CSL
  • BD Biosciences
  • AMRESCO Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Thrombin (Human) Sales Value (2021-2032)
  4. 1.2.2 Global Thrombin (Human) Sales Volume (2021-2032)
  5. 1.2.3 Global Thrombin (Human) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Thrombin (Human) Market Dynamics
  1. 2.1 Thrombin (Human) Industry Trends
  2. 2.2 Thrombin (Human) Industry Drivers
  3. 2.3 Thrombin (Human) Industry Opportunities and Challenges
  4. 2.4 Thrombin (Human) Industry Restraints
3 Thrombin (Human) Market by Company
  1. 3.1 Global Thrombin (Human) Company Revenue Ranking in 2025
  2. 3.2 Global Thrombin (Human) Revenue by Company (2021-2026)
  3. 3.3 Global Thrombin (Human) Sales Volume by Company (2021-2026)
  4. 3.4 Global Thrombin (Human) Average Price by Company (2021-2026)
  5. 3.5 Global Thrombin (Human) Company Ranking (2024-2026)
  6. 3.6 Global Thrombin (Human) Company Manufacturing Base and Headquarters
  7. 3.7 Global Thrombin (Human) Company Product Type and Application
  8. 3.8 Global Thrombin (Human) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Thrombin (Human) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Thrombin (Human) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Thrombin (Human) Market by Type
  1. 4.1 Thrombin (Human) Type Introduction
  2. 4.1.1 500IU/Vial
  3. 4.1.2 1000IU/Vial
  4. 4.1.3 2500IU/Vial
  5. 4.2 Global Thrombin (Human) Sales Volume by Type
  6. 4.2.1 Global Thrombin (Human) Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Thrombin (Human) Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Thrombin (Human) Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Thrombin (Human) Sales Value by Type
  10. 4.3.1 Global Thrombin (Human) Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Thrombin (Human) Sales Value by Type (2021-2032)
  12. 4.3.3 Global Thrombin (Human) Sales Value Share by Type (2021-2032)
5 Thrombin (Human) Market by Application
  1. 5.1 Thrombin (Human) Application Introduction
  2. 5.1.1 Biotechnology
  3. 5.1.2 Microbiology
  4. 5.1.3 Medicine
  5. 5.1.4 Others
  6. 5.2 Global Thrombin (Human) Sales Volume by Application
  7. 5.2.1 Global Thrombin (Human) Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Thrombin (Human) Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Thrombin (Human) Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Thrombin (Human) Sales Value by Application
  11. 5.3.1 Global Thrombin (Human) Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Thrombin (Human) Sales Value by Application (2021-2032)
  13. 5.3.3 Global Thrombin (Human) Sales Value Share by Application (2021-2032)
6 Thrombin (Human) Regional Sales and Value Analysis
  1. 6.1 Global Thrombin (Human) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Thrombin (Human) Sales by Region (2021-2032)
  3. 6.2.1 Global Thrombin (Human) Sales by Region: 2021-2026
  4. 6.2.2 Global Thrombin (Human) Sales by Region (2027-2032)
  5. 6.3 Global Thrombin (Human) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Thrombin (Human) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Thrombin (Human) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Thrombin (Human) Sales Value by Region (2027-2032)
  9. 6.5 Global Thrombin (Human) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Thrombin (Human) Sales Value (2021-2032)
  12. 6.6.2 North America Thrombin (Human) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Thrombin (Human) Sales Value (2021-2032)
  15. 6.7.2 Europe Thrombin (Human) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Thrombin (Human) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Thrombin (Human) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Thrombin (Human) Sales Value (2021-2032)
  21. 6.9.2 South America Thrombin (Human) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Thrombin (Human) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Thrombin (Human) Sales Value Share by Country, 2025 VS 2032
7 Thrombin (Human) Country-level Sales and Value Analysis
  1. 7.1 Global Thrombin (Human) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Thrombin (Human) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Thrombin (Human) Sales by Country (2021-2032)
  4. 7.3.1 Global Thrombin (Human) Sales by Country (2021-2026)
  5. 7.3.2 Global Thrombin (Human) Sales by Country (2027-2032)
  6. 7.4 Global Thrombin (Human) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Thrombin (Human) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Thrombin (Human) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Thrombin (Human) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Thrombin (Human) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Thrombin (Human) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Thrombin (Human) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Thrombin (Human) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Thrombin (Human) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Thrombin (Human) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Thrombin (Human) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Thrombin (Human) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Thrombin (Human) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Thrombin (Human) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Thrombin (Human) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Thrombin (Human) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Thrombin (Human) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Thrombin (Human) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Thrombin (Human) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Thrombin (Human) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Thrombin (Human) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Thrombin (Human) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Thrombin (Human) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Thrombin (Human) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Thrombin (Human) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Thrombin (Human) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Thrombin (Human) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Thrombin (Human) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Thrombin (Human) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Thrombin (Human) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Thrombin (Human) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Thrombin (Human) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Thrombin (Human) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Thrombin (Human) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Thrombin (Human) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Thrombin (Human) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Thrombin (Human) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Thrombin (Human) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Thrombin (Human) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Thrombin (Human) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Thrombin (Human) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Thrombin (Human) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Thrombin (Human) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Thrombin (Human) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Thrombin (Human) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Thrombin (Human) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Thrombin (Human) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Thrombin (Human) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Thrombin (Human) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Thrombin (Human) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Thrombin (Human) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Thrombin (Human) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Thrombin (Human) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Thrombin (Human) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Thrombin (Human) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Thrombin (Human) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Thrombin (Human) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Thrombin (Human) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Thrombin (Human) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Thrombin (Human) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Thrombin (Human) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Thrombin (Human) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Thrombin (Human) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Thrombin (Human) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Thrombin (Human) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Thrombin (Human) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Thrombin (Human) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Thrombin (Human) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Thrombin (Human) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Thrombin (Human) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Thrombin (Human) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Thrombin (Human) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Thrombin (Human) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Thrombin (Human) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Thrombin (Human) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Thrombin (Human) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Thrombin (Human) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Thrombin (Human) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Thrombin (Human) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Thrombin (Human) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Thrombin (Human) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Thrombin (Human) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Thrombin (Human) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Thrombin (Human) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Thrombin (Human) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Thrombin (Human) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Thrombin (Human) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Shanghai RAAS
  2. 8.1.1 Shanghai RAAS Company Information
  3. 8.1.2 Shanghai RAAS Business Overview
  4. 8.1.3 Shanghai RAAS Thrombin (Human) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Shanghai RAAS Thrombin (Human) Product Portfolio
  6. 8.1.5 Shanghai RAAS Recent Developments
  7. 8.2 Hualan Biological
  8. 8.2.1 Hualan Biological Company Information
  9. 8.2.2 Hualan Biological Business Overview
  10. 8.2.3 Hualan Biological Thrombin (Human) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Hualan Biological Thrombin (Human) Product Portfolio
  12. 8.2.5 Hualan Biological Recent Developments
  13. 8.3 Bayer
  14. 8.3.1 Bayer Company Information
  15. 8.3.2 Bayer Business Overview
  16. 8.3.3 Bayer Thrombin (Human) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Bayer Thrombin (Human) Product Portfolio
  18. 8.3.5 Bayer Recent Developments
  19. 8.4 Baxter
  20. 8.4.1 Baxter Company Information
  21. 8.4.2 Baxter Business Overview
  22. 8.4.3 Baxter Thrombin (Human) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Baxter Thrombin (Human) Product Portfolio
  24. 8.4.5 Baxter Recent Developments
  25. 8.5 Vitrolife AB
  26. 8.5.1 Vitrolife AB Company Information
  27. 8.5.2 Vitrolife AB Business Overview
  28. 8.5.3 Vitrolife AB Thrombin (Human) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Vitrolife AB Thrombin (Human) Product Portfolio
  30. 8.5.5 Vitrolife AB Recent Developments
  31. 8.6 Sigma-Aldrich Corporation
  32. 8.6.1 Sigma-Aldrich Corporation Company Information
  33. 8.6.2 Sigma-Aldrich Corporation Business Overview
  34. 8.6.3 Sigma-Aldrich Corporation Thrombin (Human) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Sigma-Aldrich Corporation Thrombin (Human) Product Portfolio
  36. 8.6.5 Sigma-Aldrich Corporation Recent Developments
  37. 8.7 PromoCell GmbH
  38. 8.7.1 PromoCell GmbH Company Information
  39. 8.7.2 PromoCell GmbH Business Overview
  40. 8.7.3 PromoCell GmbH Thrombin (Human) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 PromoCell GmbH Thrombin (Human) Product Portfolio
  42. 8.7.5 PromoCell GmbH Recent Developments
  43. 8.8 Octapharma
  44. 8.8.1 Octapharma Company Information
  45. 8.8.2 Octapharma Business Overview
  46. 8.8.3 Octapharma Thrombin (Human) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Octapharma Thrombin (Human) Product Portfolio
  48. 8.8.5 Octapharma Recent Developments
  49. 8.9 Life Technologies Corporation
  50. 8.9.1 Life Technologies Corporation Company Information
  51. 8.9.2 Life Technologies Corporation Business Overview
  52. 8.9.3 Life Technologies Corporation Thrombin (Human) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Life Technologies Corporation Thrombin (Human) Product Portfolio
  54. 8.9.5 Life Technologies Corporation Recent Developments
  55. 8.10 Kedrion
  56. 8.10.1 Kedrion Company Information
  57. 8.10.2 Kedrion Business Overview
  58. 8.10.3 Kedrion Thrombin (Human) Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Kedrion Thrombin (Human) Product Portfolio
  60. 8.10.5 Kedrion Recent Developments
  61. 8.11 Grifols
  62. 8.11.1 Grifols Company Information
  63. 8.11.2 Grifols Business Overview
  64. 8.11.3 Grifols Thrombin (Human) Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Grifols Thrombin (Human) Product Portfolio
  66. 8.11.5 Grifols Recent Developments
  67. 8.12 CSL
  68. 8.12.1 CSL Company Information
  69. 8.12.2 CSL Business Overview
  70. 8.12.3 CSL Thrombin (Human) Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 CSL Thrombin (Human) Product Portfolio
  72. 8.12.5 CSL Recent Developments
  73. 8.13 BD Biosciences
  74. 8.13.1 BD Biosciences Company Information
  75. 8.13.2 BD Biosciences Business Overview
  76. 8.13.3 BD Biosciences Thrombin (Human) Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 BD Biosciences Thrombin (Human) Product Portfolio
  78. 8.13.5 BD Biosciences Recent Developments
  79. 8.14 AMRESCO Inc
  80. 8.14.1 AMRESCO Inc Company Information
  81. 8.14.2 AMRESCO Inc Business Overview
  82. 8.14.3 AMRESCO Inc Thrombin (Human) Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 AMRESCO Inc Thrombin (Human) Product Portfolio
  84. 8.14.5 AMRESCO Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Thrombin (Human) Value Chain Analysis
  2. 9.1.1 Thrombin (Human) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Thrombin (Human) Sales Mode & Process
  6. 9.2 Thrombin (Human) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Thrombin (Human) Distributors
  9. 9.2.3 Thrombin (Human) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst